CFM Wealth Partners’s Gilead Sciences GILD Stock Holding History

CFM Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,450	Closed	-$223K	–	178
2021 Q1	$223K	Sell	3,450 -4,277	-55%	-$276K	0.07%	155
2020 Q4	$450K	Sell	7,727 -1,865	-19%	-$113K	0.14%	93
2020 Q3	$610K	Sell	9,592 -295	-3%	-$20.5K	0.22%	76
2020 Q2	$760K	Sell	9,887 -219	-2%	-$16.8K	0.29%	72
2020 Q1	$756K	Buy	10,106 +53	+0.5%	+$3.66K	0.35%	59
2019 Q4	$635K	Buy	+10,053	New	+$655K	0.23%	76

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CFM Wealth Partners's GILD Position: Q2 2021 in Review

CFM Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 3,450 shares — an estimated $223K sold.

CFM Wealth Partners first reported a position in GILD in Q4 2019 and held it in 6 quarters. The position peaked at $760K in Q2 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

CFM Wealth Partners reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
CFM Wealth Partners sold 3,450 Gilead Sciences shares in Q2 2021, an estimated $223K.
CFM Wealth Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 6 quarters.
CFM Wealth Partners's Gilead Sciences position peaked at $760K in Q2 2020.
1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on CFM Wealth Partners's 13F filing for Q2 2021, filed 21 Jul 2021.